BioArctic AB (publ) (BIOA-B) - Total Liabilities

Latest as of March 2026: Skr481.21 Million SEK ≈ $51.79 Million USD

Based on the latest financial reports, BioArctic AB (publ) (BIOA-B) has total liabilities worth Skr481.21 Million SEK (≈ $51.79 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check BioArctic AB (publ) liquid asset ratio to evaluate the company's liquid asset resilience ratio.

BioArctic AB (publ) - Total Liabilities Trend (2015–2025)

This chart illustrates how BioArctic AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see BioArctic AB (publ) balance sheet assets.

BioArctic AB (publ) Competitors by Total Liabilities

The table below lists competitors of BioArctic AB (publ) ranked by their total liabilities.

Company	Country	Total Liabilities
Chongqing Zongshen Power Machinery Co Ltd SHE:001696	China	CN¥6.77 Billion
Hugo Boss AG XETRA:BOSS	Germany	€2.11 Billion
Opendoor Technologies Inc NASDAQ:OPEN	USA	$1.40 Billion
Peab AB (publ) ST:PEAB-B	Sweden	Skr31.32 Billion
Attica Bank S.A. AT:TATT	Greece	€6.29 Billion
Hugo Boss AG F:BOSA	Germany	€1.90 Billion
Silvercorp Metals Inc TO:SVM	Canada	CA$356.09 Million
Hawkins Inc NASDAQ:HWKN	USA	$467.69 Million

Liability Composition Analysis (2015–2025)

This chart breaks down BioArctic AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BioArctic AB (publ) (BIOA-B) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.54	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BioArctic AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BioArctic AB (publ) (2015–2025)

The table below shows the annual total liabilities of BioArctic AB (publ) from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr608.14 Million ≈ $65.45 Million	+180.59%
2024-12-31	Skr216.74 Million ≈ $23.32 Million	+55.37%
2023-12-31	Skr139.50 Million ≈ $15.01 Million	+93.58%
2022-12-31	Skr72.06 Million ≈ $7.76 Million	-33.92%
2021-12-31	Skr109.05 Million ≈ $11.74 Million	-23.75%
2020-12-31	Skr143.01 Million ≈ $15.39 Million	-31.52%
2019-12-31	Skr208.84 Million ≈ $22.47 Million	-44.36%
2018-12-31	Skr375.31 Million ≈ $40.39 Million	-25.59%
2017-12-31	Skr504.35 Million ≈ $54.28 Million	-22.07%
2016-12-31	Skr647.22 Million ≈ $69.65 Million	+2735.43%
2015-12-31	Skr22.83 Million ≈ $2.46 Million	--

About BioArctic AB (publ)

ST:BIOA-B Sweden Biotechnology

Market Cap

$2.54 Billion

Skr23.59 Billion SEK

Market Cap Rank

#5406 Global

#73 in Sweden

Share Price

Skr317.40

Change (1 day)

-2.46%

52-Week Range

Skr263.60 - Skr364.40

All Time High

Skr377.80